Bio-Path Holdings, Inc.
BPTH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $158 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $41 | $32 | $0 | $33 |
| Gross Profit | -$41 | -$32 | $79 | -$33 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $4,048 | $1,977 | $1,817 | $1,317 |
| G&A Expenses | $514 | $1,264 | $808 | $1,317 |
| SG&A Expenses | $514 | $1,264 | $808 | $1,317 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$32 | $0 | $0 |
| Operating Expenses | $4,562 | $3,209 | $2,625 | $2,634 |
| Operating Income | -$4,562 | -$3,241 | -$2,625 | -$2,634 |
| % Margin | – | – | -1,661.4% | – |
| Other Income/Exp. Net | -$35 | $389 | -$128 | $519 |
| Pre-Tax Income | -$4,597 | -$2,852 | -$2,753 | -$2,115 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,597 | -$2,852 | -$2,753 | -$2,115 |
| % Margin | – | – | -1,742.4% | – |
| EPS | -0.55 | -0.4 | -1.15 | -0.7 |
| % Growth | -37.5% | 65.2% | -64.3% | – |
| EPS Diluted | -0.55 | -0.4 | -1.15 | -0.7 |
| Weighted Avg Shares Out | 8,308 | 7,062 | 2,401 | 3,017 |
| Weighted Avg Shares Out Dil | 8,308 | 7,062 | 2,401 | 3,017 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $4 | $4 |
| Interest Expense | $35 | $5 | $0 | $0 |
| Depreciation & Amortization | $41 | $32 | $47 | $33 |
| EBITDA | -$4,521 | -$2,815 | -$2,578 | -$2,601 |
| % Margin | – | – | -1,631.6% | – |